Pseudohyperparathyroidism: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 17: Line 17:
{{Editor Help}}
{{Editor Help}}


 
Hypercalcemia occurring in association with a malignant neoplasm but without skeletal metastases or primary hyperparathyroidism, possibly caused by the formation of parathyroid hormone by nonparathyroid tumor tissue.





Revision as of 10:19, 12 January 2009

Pseudohyperparathyroidism

WikiDoc Resources for Pseudohyperparathyroidism

Articles

Most recent articles on Pseudohyperparathyroidism

Most cited articles on Pseudohyperparathyroidism

Review articles on Pseudohyperparathyroidism

Articles on Pseudohyperparathyroidism in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pseudohyperparathyroidism

Images of Pseudohyperparathyroidism

Photos of Pseudohyperparathyroidism

Podcasts & MP3s on Pseudohyperparathyroidism

Videos on Pseudohyperparathyroidism

Evidence Based Medicine

Cochrane Collaboration on Pseudohyperparathyroidism

Bandolier on Pseudohyperparathyroidism

TRIP on Pseudohyperparathyroidism

Clinical Trials

Ongoing Trials on Pseudohyperparathyroidism at Clinical Trials.gov

Trial results on Pseudohyperparathyroidism

Clinical Trials on Pseudohyperparathyroidism at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pseudohyperparathyroidism

NICE Guidance on Pseudohyperparathyroidism

NHS PRODIGY Guidance

FDA on Pseudohyperparathyroidism

CDC on Pseudohyperparathyroidism

Books

Books on Pseudohyperparathyroidism

News

Pseudohyperparathyroidism in the news

Be alerted to news on Pseudohyperparathyroidism

News trends on Pseudohyperparathyroidism

Commentary

Blogs on Pseudohyperparathyroidism

Definitions

Definitions of Pseudohyperparathyroidism

Patient Resources / Community

Patient resources on Pseudohyperparathyroidism

Discussion groups on Pseudohyperparathyroidism

Patient Handouts on Pseudohyperparathyroidism

Directions to Hospitals Treating Pseudohyperparathyroidism

Risk calculators and risk factors for Pseudohyperparathyroidism

Healthcare Provider Resources

Symptoms of Pseudohyperparathyroidism

Causes & Risk Factors for Pseudohyperparathyroidism

Diagnostic studies for Pseudohyperparathyroidism

Treatment of Pseudohyperparathyroidism

Continuing Medical Education (CME)

CME Programs on Pseudohyperparathyroidism

International

Pseudohyperparathyroidism en Espanol

Pseudohyperparathyroidism en Francais

Business

Pseudohyperparathyroidism in the Marketplace

Patents on Pseudohyperparathyroidism

Experimental / Informatics

List of terms related to Pseudohyperparathyroidism

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Hypercalcemia occurring in association with a malignant neoplasm but without skeletal metastases or primary hyperparathyroidism, possibly caused by the formation of parathyroid hormone by nonparathyroid tumor tissue.



Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs

Template:SIB


Template:WikiDoc Sources